Chaza Alaji: Factor X From Inherited Deficiency to Acquired Deficiency in AL Amyloidosis
Chaza Alaji, Medical Laboratory Specialist and Supervisor at Privat university-private laboratory-general hospital, shared a post on LinkedIn:
“From Umbilical Cord Bleeding to Amyloidosis: The Hidden Story of Factor X
Factor X (FX), or Stuart Prower factor, occupies a critical position in the coagulation cascade.
It is the point where the intrinsic and extrinsic pathways converge into the common pathway.
Once activated to FXa, it combines with factor Va, calcium, and phospholipid to form the prothrombinase complex, converting prothrombin (FII) into thrombin (FIIa) a pivotal step in fibrin generation.
But what makes FX particularly interesting is that the same laboratory abnormality can have very different clinical origins.
When bleeding starts at the umbilical cord
Inherited FX deficiency is a rare autosomal recessive bleeding disorder caused by pathogenic variants in F10.
Severe deficiency may present early, sometimes with umbilical stump bleeding, followed by mucosal, soft tissue, gastrointestinal, or postoperative bleeding.
Severe cases may also develop joint or intracranial bleeding.
The laboratory pattern is characteristic:
- Prolonged PT
- Prolonged aPTT
- Normal thrombin time (TT)
Why?
Because FX belongs to the common pathway. Its deficiency can therefore prolong both PT and aPTT, while TT remains normal because the TT assay bypasses FX by adding thrombin directly.
The mixing study provides the next clue
If PT and aPTT correct after mixing patient plasma 1 over 1 with normal plasma, a factor deficiency becomes more likely.
Specific FX activity testing then establishes the diagnosis and determines its severity.
Antigen testing may additionally distinguish:
Type I reduced quantity of FX
from
Type II dysfunctional FX protein.
But FX deficiency is not always inherited…
One of the most fascinating acquired associations is systemic AL amyloidosis.
In some patients with AL amyloidosis, circulating FX becomes associated with amyloid deposits, particularly within the reticuloendothelial system, leading to accelerated clearance of FX from the circulation.
The result can be an acquired FX deficiency:
FX activity prolonged PT or aPTT leads to bleeding
This creates an important diagnostic lesson:
Prolonged PT and aPTT do not automatically mean liver disease, vitamin K deficiency, or DIC.
The clinical context matters.
The laboratory connection
When both PT and aPTT are prolonged while TT remains normal, the differential diagnosis should include abnormalities affecting the common pathway particularly factors II, V, and X, depending on the clinical and laboratory context.
A correcting mixing study supports a factor deficiency, while specific factor assays identify the deficient factor.
Take home message
Factor X is more than a number on a coagulation report.
It connects clinical bleeding,
From a newborn with unexplained umbilical cord bleeding to an adult. pathway can turn a nonspecific coagulation abnormality into a precise diagnosis.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters